Inventor
MATULIC-ADAMIC JASENKA
US30 patents
⚠️ This page may combine multiple inventors who share the name “MATULIC-ADAMIC JASENKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIBOZYME PHARM INC
20 patentsUS6362323B1Mar 26, 2002
Non-nucleotide containing nucleic acid
RIBOZYME PHARM INC179 citations99
US6248878B1Jun 19, 2001
Nucleoside analogs
RIBOZYME PHARM INC264 citations99
US6117657ASep 12, 2000
Non-nucleotide containing enzymatic nucleic acid
RIBOZYME PHARM INC253 citations99
US5891683AApr 6, 1999
Non-nucleotide containing enzymatic nucleic acid
RIBOZYME PHARM INC104 citations99
US6528640B1Mar 4, 2003
Synthetic ribonucleic acids with RNAse activity
RIBOZYME PHARM INC283 citations98
US6395713B1May 28, 2002
Compositions for the delivery of negatively charged molecules
RIBOZYME PHARM INC367 citations98
US5998203ADec 7, 1999
Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
RIBOZYME PHARM INC784 citations98
US6586238B1Jul 1, 2003
Enzymatic nucleic acids containing 5′-and or 3′-cap structures
RIBOZYME PHARM INC43 citations92
US6482932B1Nov 19, 2002
Nucleoside triphosphates and their incorporation into oligonucleotides
RIBOZYME PHARM INC21 citations92
US6127535AOct 3, 2000
Nucleoside triphosphates and their incorporation into oligonucleotides
RIBOZYME PHARM INC23 citations92
US5672501ASep 30, 1997
Base-modified enzymatic nucleic acid
RIBOZYME PHARM INC20 citations92
US6093555AJul 25, 2000
Amido and peptido modified enzymatic nucleic acid molecules
RIBOZYME PHARM INC30 citations91
US5783425AJul 21, 1998
Amino and peptido modified enzymatic nucleic acid
RIBOZYME PHARM INC22 citations91
US6489465B2Dec 3, 2002
Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
RIBOZYME PHARM INC7 citations74
US6316612B1Nov 13, 2001
Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
RIBOZYME PHARM INC11 citations74
US6555668B2Apr 29, 2003
Non-nucleotide containing enzymatic nucleic acid
RIBOZYME PHARM INC2 citations63
US6268534B1Jul 31, 2001
Process for the synthesis of N,N-Dioleyl-N,N-Dimethylammonium Chloride
RIBOZYME PHARM INC2 citations63
US5506349AApr 9, 1996
Chemical synthesis of 2', 3'-dideoxycytidine
RIBOZYME PHARM INC4 citations63
US6509460B1Jan 21, 2003
Nucleoside triphosphates and their incorporation into oligonucleotides
RIBOZYME PHARM INC4 citations62
US6379954B1Apr 30, 2002
Amido and peptido modified catalytic oligonucleotides
RIBOZYME PHARM INC2 citations61
SIRNA THERAPEUTICS INC
7 patentsUS7109165B2Sep 19, 2006
Conjugates and compositions for cellular delivery
SIRNA THERAPEUTICS INC90 citations99
US6849726B2Feb 1, 2005
Non-nucleotide containing RNA
SIRNA THERAPEUTICS INC129 citations99
US6673611B2Jan 6, 2004
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
SIRNA THERAPEUTICS INC218 citations98
US6617438B1Sep 9, 2003
Oligoribonucleotides with enzymatic activity
SIRNA THERAPEUTICS INC312 citations97
US7858625B2Dec 28, 2010
Conjugates and compositions for cellular delivery
SIRNA THERAPEUTICS INC22 citations93
US6797815B2Sep 28, 2004
Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
SIRNA THERAPEUTICS INC16 citations93
US7553830B2Jun 30, 2009
Compositions for the delivery of negatively charged molecules
SIRNA THERAPEUTICS INC20 citations91